Clinical effects on the chemotherapy of neoadjuvent chomotherapy for surgical resection in patients with stage ⅢA non-small cell lung cancer / 中国基层医药

ABSTRACT

Objective To investigate the effect of neoadjuvent chomotherapy of paclitexel plus eisplatin for improving the surgical resection rate of stage ⅢA non-small cell lung cancer(NSCLC).Methods 46 patients with stage ⅢA NSCLC were randomly divided into neoadjuvant chemotherapy group(25 caeses) and simple operative group(25 cases).Neoedjuvant chemotherapy group(NCG) received two-cycle chemotherapy and then underwent operation.Simple operative group(SOG) was only treated by operation.Results The operative resection rate of NCG was 99.0%,radical resection rate was 64.0%.It was higher obviously than that simple operative group(SOG)(P